Search

The recent marketing of "at home" genomic tests for disease risk may be premature, according to Dr. Kenneth Offit, MD, MPH, Chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center (MSKCC).

… Tuesday, March 18, 2008 The recent marketing of “at home” genomic tests for disease risk may be premature, according to Dr. Kenneth Offit, MD, MPH , Chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center (MSKCC). “Health professionals are now faced with the prospect of their

Meet Dr. Monique James, who is part of MSK’s Department of Psychiatry and Behavioral Sciences. Her journey with MSK started 18 years ago before she even started medical school. 

… Tuesday, January 21, 2025 In 2017, Monique James, MD joined the Department of Psychiatry and Behavioral Sciences at Memorial Sloan Kettering Cancer Center (MSK), but her journey with MSK started 18 years before she even started medical school.  “I worked as a session assistant — when they were called

Learn more about the work of MSK researchers being presented at the 2018 meeting of the American Society of Hematology.

… Monday, December 3, 2018 The American Society of Hematology (ASH) annual meeting is the world’s premier event devoted to the study of blood cancers and disorders. More than 25,000 people are attending the 2018 assembly, held December 1 through 4 in San Diego. Memorial Sloan Kettering researchers at the

A rare form of stomach cancer caused by an inherited gene mutation can be avoided by having the stomach removed — and many people can adjust to life afterward.

… Wednesday, November 16, 2016 Summary People with an inherited mutation in the CDH1 gene are at a very high risk of developing a rare type of stomach cancer . Having the stomach removed, which can be performed using minimally invasive methods, can eliminate this risk. Most people recover well from the

A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs.

… Friday, August 24, 2012 Summary A new Memorial Sloan Kettering study has identified one of the proteins fueling the spread of some breast cancers, and researchers hope their findings will lead to the development of new diagnostic tools and drugs. Cancer experts have long known that virtually all cancers

A Q&A with MSK Urologic Surgeon Richard Matulewicz, MD, MSCI, MS.

… Monday, September 9, 2024 Since 2013, MSK has offered primary retroperitoneal lymph node dissection (RPLND) to select patients with low-volume incident or relapsed seminoma metastatic only to the retroperitoneum, in lieu of the traditional standards of care which were previously chemotherapy or radiation

Hear from Memorial Sloan Kettering breast surgical oncologist Tracy-Ann Moo about her experience as a woman of color in medicine.

… Wednesday, February 10, 2021 In honor of Black History Month, we spoke with Memorial Sloan Kettering breast surgical oncologist Tracy-Ann Moo about the challenges of being a person of color in medicine — especially in the age of COVID-19. The most recent data from the Association of American Medical

Investigators at MSK are developing new immunotherapy treatments that rely on engineering T cells to recognize mutated proteins that are unique to cancer.

… Friday, April 29, 2022 Immunotherapy is an increasingly important form of cancer treatment. It encompasses a class of cancer therapies that harness the immune system’s natural ability to recognize and eliminate tumor cells. Most immunotherapies work by boosting the power of a type of white blood cell

Learn about seven nursing staff members were honored with a Robbins Family Award for Nursing Excellence.

… Thursday, October 1, 2020 Andrea Smith Excellence in Nursing Leadership — Andrea Smith (Nurse Leader, Outpatient Nursing Services, Evelyn H. Lauder Breast Center) Leon Chen Excellence in Advanced Nursing Practice — Leon Chen (Nurse Practitioner, Critical Care, Intensive Care Unit) Jessica Agostini Excellence

Memorial Sloan Kettering Cancer Center has announced the appointment of medical oncologist Paul Sabbatini to the new position of Deputy Physician-in-Chief for Clinical Research.

… Thursday, January 17, 2013 Memorial Sloan Kettering Cancer Center has announced the appointment of medical oncologist Paul Sabbatini to the new position of Deputy Physician-in-Chief for Clinical Research. In this role, Dr. Sabbatini will streamline and accelerate the clinical research process while ensuring